Classification of ultrasonographic images of small hepatocellular carcinoma using galactose-based contrast agent: Relation between image patterns and histologic features

Journal of Medical Ultrasonics

Volumn 31, Issue 3, 2004, Pages 111-120

  Matsuda, Yasuo ^a   Yabuuchi, Iwao ^b   Ito, Toshikazu ^a   Arima, Ryoichi ^b  

^a OTEMAE HOSPITAL   (Japan)

^b Otemae Hospital   (Japan)

Author keywords

Contrast enhancement; Galactose based contrast agent; Hepatocellular carcinoma; Ultrasound

Indexed keywords

CONTRAST MEDIUM; GALACTOSE; SHU 508;

AGED; ARTERY BLOOD FLOW; ARTICLE; B SCAN; CANCER CLASSIFICATION; CELL DIFFERENTIATION; CONTRAST ENHANCEMENT; DOPPLER FLOWMETRY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; STATISTICAL SIGNIFICANCE; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 20944440055     PISSN: 13464523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10396-004-0018-7     Document Type: Article

References (25)

1. Choi BI, Kim TK, Han JK, et al. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 2000;214:381-6.
2. Wilson SR, Burns PN, Muradali D, et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellualr carcinoma, and metastasis. Radiology 2000;215:153-61.
3. Furuse J, Nagase M, Ishii H, et al. Contrast enhanced patterns of hepatic tumors during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 2003;76:385-92.
4. Kamiyama N, Moriyasu F, Mine Y, et al. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol 1999;25:411-20.
5. Lin TY, Chen KM, Chen CC. Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience. Br J Surg 1987;74:839-42.
6. Nakashima T, Kojiro M. Hepatocellular carcinoma: an atlas of its pathology. Tokyo: Springer; 1987. p. 117-9.
7. Hsu HC, Sheu JC, Lin YH, et al. Prognostic histologic features of resected small hepatocellualr carcinoma (HCC) in Taiwan: a comparison with resected large HCC. Cancer 1985;56:672-80.
8. Shimada M, Takenaka K, Taguchi K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellualr carcinoma. Ann Surg 1998;227:80-5.
9. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127:603-8.
10. Dodd GD III, Memel DS, Baron RL, et al. Portal vein thrombosis in patients with cirrhosis: dose sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol 1995;165:573-7.
11. Lencioni R, Caramella D, Sanguinetti F, et al. Portal vein thrombosis after percutaneous ethanol injection for hepatocellular carcinoma: value of color Doppler sonography in distinguishing chemical and tumor thrombi. AJR Am J Roentgenol 1995;164: 1125-30.
12. Tublin ME, Dodd GD III, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 1997;168:719-23.
13. Soyer P, Chacroun K, Pelage JP, et al. Hepatocarcinoma invasion of the portal vein: detection using lipiodol computed tomography: apropos of 2 cases. J Radiol 1999;80:47-9.
14. Hann LE, Schwartz LH, Panicek DM, et al. Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology 1998;206:651-6.
15. Vilana R, Bru C, Bruix J, et al. Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis. AJR Am J Roentgenol 1993;160:1285-7.
16. Kubo S, Kinoshita H, Hirohashi K, et al. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Hepatogastroenterology 1999;46: 3212-5.
17. Arii S, Monden K, Niwano M, et al. Results of surgical treatment for hepatocellualr carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 1998;5:86-92.
18. Arii S, Teramoto K, Kawamura T, et al. Characteristics of recurrent hepatocellular carcinoma in Japan and surgical experience. J Hepatobiliary Pancreat Surg 2001;8:397-403.
19. Matsuda Y, Ito T, Oguchi Y, et al. Rationale of surgical management for recurrent hepatocellualr carcinoma. Ann Surg 1993;217: 28-34.
20. Schlief R, Schurman R, Niendorf HP. Basic properties and results of clinical trials of ultrasound contrast agents based on galactose. Ann Acad Med Singapore 1993;22:762-7.
21. Schwarz KQ, Becher H, Schimpfky C, et al. Doppler enhancement with SH U 508A in multiple vascular regions. Radiology 1994;193: 195-201.
22. 2 microbubbles. Radiology 1986;161:701-5.
23. 2 microbubbles. Radiology 1992;182:155-60.
24. Nomura Y, Matsuda Y, Yabuuchi I, et al. Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles. Radiology 1993;187:353-6.
25. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985;161:346-50.